Figure 3From: The efficacy and safety of febuxostat for urate lowering in gout patients ≥65 years of age Mean Percent Change From Baseline In Serum Urate at Each Scheduled Visit. a p < 0.001 vs allopurinol; b p < 0.001 vs febuxostat 40 mg; c p ≤ 0.027 vs allopurinol. Error bars represent standard deviation.Back to article page